Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings

The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on a...

Full description

Saved in:
Bibliographic Details
Published inPsychological medicine Vol. 39; no. 11; pp. 1763 - 1777
Main Authors Navari, S., Dazzan, P.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.11.2009
Subjects
Online AccessGet full text
ISSN0033-2917
1469-8978
1469-8978
DOI10.1017/S0033291709005315

Cover

Loading…
Abstract The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.
AbstractList The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type?BACKGROUNDThe potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type?A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed.METHODA systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed.Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal.RESULTSThirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal.Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.CONCLUSIONSAntipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.
The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.
The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.
Background. The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? Method. A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Results. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Conclusions. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. Adapted from the source document.
Background: The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? Method: A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Results: Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Conclusions: Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. [PUBLICATION ABSTRACT]
Author Dazzan, P.
Navari, S.
Author_xml – sequence: 1
  givenname: S.
  surname: Navari
  fullname: Navari, S.
  email: serena.navari@iop.kcl.ac.uk
  organization: 1Division of Psychological Medicine and Psychiatry, Institute of Psychiatry, King's College London, UK
– sequence: 2
  givenname: P.
  surname: Dazzan
  fullname: Dazzan, P.
  organization: 1Division of Psychological Medicine and Psychiatry, Institute of Psychiatry, King's College London, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21990770$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19338710$$D View this record in MEDLINE/PubMed
BookMark eNqFkkFv1DAQhS1URLeFH8AFWUjAKeCx4zg-oaq0pVCEoCAQF8uxncUlcRY7Afbf42iXViqinGxpvjejeW_20E4YgkPoPpCnQEA8OyeEMSpBEEkIZ8BvoQWUlSxqKeodtJjLxVzfRXspXRACDEp6B-2CZKwWQBZIvRiwDqNfpbX5OozeYBunZcK6bZ0ZcRO1DziNcTLjFN1zfIDTOo2u1zOqg8Um-vzVHY7uh3c_8dDiN-9PceuD9WGZ7qLbre6Su7d999HH46MPhy-Ls7cnp4cHZ4XhlRiLGrhmoiaUggPKrKOCsBZkzVhrTVMb6nhlqeGltLxyoqYNlNo2phbWGm3ZPnqy6buKw_fJpVH1PhnXdTq4YUpKsJIIWlcyk49vJLlgAJVg_wUpMEZKPoMPr4EXwxRDXldRUpaSAxUZerCFpqZ3Vq2i73Vcqz9RZODRFtAp-9lGHYxPlxwFKYkQMwcbzsQhpejaq1ZEzWeh_jqLrBHXNMaPOcIhjDng7kZlsVH6nPqvy1E6flPZI8FVdfJOnX_5zMTr6pX6lHm2naT7Jnq7dFdm_HvKb_vT1sM
CODEN PSMDCO
CitedBy_id crossref_primary_10_1016_j_neubiorev_2010_11_004
crossref_primary_10_3389_fpsyt_2022_802025
crossref_primary_10_1016_j_ajp_2016_10_031
crossref_primary_10_1016_j_euroneuro_2016_09_371
crossref_primary_10_1016_j_pscychresns_2011_08_011
crossref_primary_10_1017_S0033291710001686
crossref_primary_10_1016_j_schres_2011_08_021
crossref_primary_10_1111_acps_12440
crossref_primary_10_3389_fnhum_2016_00373
crossref_primary_10_1016_j_euroneuro_2012_09_001
crossref_primary_10_1016_j_pscychresns_2010_06_006
crossref_primary_10_1038_tp_2012_116
crossref_primary_10_1016_j_neubiorev_2013_01_003
crossref_primary_10_1016_j_neubiorev_2014_03_014
crossref_primary_10_1111_acps_12677
crossref_primary_10_1016_j_cortex_2012_08_027
crossref_primary_10_1016_j_nicl_2019_101959
crossref_primary_10_1016_j_bpsc_2019_10_014
crossref_primary_10_1111_j_1600_0447_2010_01632_x
crossref_primary_10_1016_j_jpsychires_2012_05_008
crossref_primary_10_1111_j_1600_0447_2012_01868_x
crossref_primary_10_1016_j_nicl_2017_11_004
crossref_primary_10_1590_1516_4446_2013_1120
crossref_primary_10_1016_j_schres_2010_10_004
crossref_primary_10_1017_S1461145710000817
crossref_primary_10_1017_S003329171100119X
crossref_primary_10_1016_j_jad_2018_11_082
crossref_primary_10_1016_j_neubiorev_2017_09_023
crossref_primary_10_1016_j_jpsychires_2013_03_010
crossref_primary_10_1017_S0033291721004098
crossref_primary_10_1016_j_schres_2013_12_015
crossref_primary_10_1177_0004867416631827
crossref_primary_10_1093_schbul_sbp151
crossref_primary_10_1016_j_biopsych_2014_05_023
crossref_primary_10_2217_npy_12_13
crossref_primary_10_1007_s12021_013_9184_3
crossref_primary_10_1016_j_schres_2013_04_029
crossref_primary_10_1017_S0033291712000098
crossref_primary_10_3389_fpsyt_2018_00217
crossref_primary_10_1016_j_pscychresns_2017_01_008
crossref_primary_10_1017_S0033291722002896
crossref_primary_10_1097_JCP_0b013e31820e3f58
crossref_primary_10_1016_j_biopsych_2015_02_008
crossref_primary_10_1111_jcpp_12307
crossref_primary_10_1016_j_eurpsy_2015_02_009
crossref_primary_10_1038_tp_2016_238
crossref_primary_10_1177_2040622320905215
crossref_primary_10_1016_j_neulet_2021_136065
crossref_primary_10_1016_j_pnpbp_2021_110251
crossref_primary_10_1111_sjop_12414
crossref_primary_10_1016_j_pscychresns_2014_11_004
crossref_primary_10_1017_S0033291710001698
crossref_primary_10_1017_S0033291717000642
crossref_primary_10_1007_s11682_018_9935_8
crossref_primary_10_1017_S0033291711002716
crossref_primary_10_1016_j_mri_2013_08_004
crossref_primary_10_1007_s10548_013_0288_8
crossref_primary_10_1017_S0033291711002157
crossref_primary_10_1016_j_schres_2015_01_021
crossref_primary_10_1016_j_schres_2016_03_039
crossref_primary_10_1016_j_pscychresns_2020_111067
crossref_primary_10_1016_j_bbr_2013_05_061
crossref_primary_10_1093_brain_awaa025
crossref_primary_10_1093_schbul_sby189
crossref_primary_10_1111_chso_12049
crossref_primary_10_1093_schbul_sbs083
crossref_primary_10_1177_02698811221087645
crossref_primary_10_1016_j_neubiorev_2016_10_004
crossref_primary_10_1016_j_neuroimage_2025_121127
crossref_primary_10_1007_s00406_016_0747_9
crossref_primary_10_1176_appi_ajp_2015_14091108
crossref_primary_10_1523_JNEUROSCI_6056_11_2012
crossref_primary_10_1186_1471_244X_13_342
crossref_primary_10_1016_j_schres_2011_07_018
crossref_primary_10_1016_j_comppsych_2018_11_014
crossref_primary_10_1016_j_nicl_2013_12_007
crossref_primary_10_1016_j_schres_2017_08_061
crossref_primary_10_1148_radiol_2016152149
crossref_primary_10_1038_npp_2016_64
crossref_primary_10_1017_S0033291710002205
crossref_primary_10_1016_j_pscychresns_2017_09_010
crossref_primary_10_1177_070674371405901003
crossref_primary_10_1177_02841851231179174
crossref_primary_10_1016_j_euroneuro_2012_08_008
crossref_primary_10_1017_S0033291713001001
crossref_primary_10_1126_scisignal_2004331
crossref_primary_10_1016_j_seizure_2022_09_006
crossref_primary_10_1007_s11920_012_0345_0
crossref_primary_10_1016_j_pscychresns_2012_09_013
crossref_primary_10_1016_j_pnpbp_2011_03_014
crossref_primary_10_1016_j_schres_2009_09_011
crossref_primary_10_3109_15622975_2014_984629
crossref_primary_10_1016_j_neuroscience_2015_07_039
crossref_primary_10_1007_s11682_017_9681_3
crossref_primary_10_1016_j_euroneuro_2011_06_004
crossref_primary_10_1016_j_pscychresns_2017_11_004
crossref_primary_10_1016_j_biopsych_2012_04_020
crossref_primary_10_1016_j_schres_2017_07_014
crossref_primary_10_1093_schbul_sbaa011
crossref_primary_10_3389_fgene_2019_00519
crossref_primary_10_1016_j_psychres_2021_113962
crossref_primary_10_1016_j_cortex_2012_01_009
crossref_primary_10_1016_j_neuroimage_2018_04_054
crossref_primary_10_1038_s41433_021_01580_4
crossref_primary_10_1016_j_tics_2015_09_009
crossref_primary_10_31887_DCNS_2014_16_4_pdazzan
crossref_primary_10_1016_j_schres_2010_09_008
crossref_primary_10_1016_j_eurpsy_2013_10_006
crossref_primary_10_1016_j_jaac_2016_01_004
crossref_primary_10_1038_tp_2015_195
crossref_primary_10_1371_journal_pone_0231669
crossref_primary_10_1016_j_schres_2024_01_031
crossref_primary_10_1002_hbm_25093
crossref_primary_10_1016_j_biopsych_2018_04_023
crossref_primary_10_1002_hbm_23906
crossref_primary_10_1007_s00115_014_4027_5
crossref_primary_10_1093_schbul_sbs152
crossref_primary_10_1016_j_pscychresns_2010_12_009
crossref_primary_10_1080_10508422_2014_880920
crossref_primary_10_1016_j_schres_2015_09_014
crossref_primary_10_1371_journal_pone_0166651
crossref_primary_10_1017_S003329171300319X
crossref_primary_10_1586_ern_11_76
crossref_primary_10_1007_s00429_018_1634_0
crossref_primary_10_1177_2045125317752915
crossref_primary_10_1017_S003329171300024X
crossref_primary_10_1038_npp_2015_90
crossref_primary_10_1007_s00406_015_0650_9
crossref_primary_10_1016_j_neuroimage_2011_05_058
crossref_primary_10_1016_j_schres_2024_05_002
crossref_primary_10_1016_j_pscychresns_2012_05_001
crossref_primary_10_1093_schbul_sbz119
crossref_primary_10_1016_j_schres_2015_09_027
crossref_primary_10_1038_s41598_019_42532_z
crossref_primary_10_3390_jcm10184131
crossref_primary_10_1038_s41598_017_10688_1
crossref_primary_10_1016_j_ajp_2024_104167
crossref_primary_10_1017_S003329170900573X
crossref_primary_10_1017_S0033291709992297
crossref_primary_10_1517_14656566_2016_1114101
crossref_primary_10_1192_bjp_bp_116_182683
crossref_primary_10_1016_j_biopsych_2017_08_011
crossref_primary_10_1016_j_schres_2016_12_008
crossref_primary_10_1016_j_pscychresns_2011_06_008
crossref_primary_10_1016_j_pscychresns_2019_06_003
crossref_primary_10_1016_j_pscychresns_2018_08_015
crossref_primary_10_1016_j_npbr_2014_01_001
crossref_primary_10_1080_17522439_2011_577588
crossref_primary_10_1186_2194_7511_1_3
crossref_primary_10_1016_j_schres_2010_08_016
crossref_primary_10_1093_schbul_sbs135
crossref_primary_10_1016_j_brainres_2015_10_002
crossref_primary_10_1007_s11682_017_9729_4
crossref_primary_10_1017_S0033291713000238
crossref_primary_10_1016_j_psychres_2024_116261
crossref_primary_10_1016_j_schres_2013_06_025
crossref_primary_10_1016_j_pscychresns_2014_12_004
crossref_primary_10_1016_j_schres_2016_01_025
crossref_primary_10_1038_s41598_019_43955_4
crossref_primary_10_1038_s41398_020_00940_0
crossref_primary_10_1016_j_euroneuro_2014_07_015
crossref_primary_10_1590_1516_4446_2014_1387
crossref_primary_10_1007_s11682_014_9313_0
crossref_primary_10_1016_j_schres_2015_06_016
crossref_primary_10_1097_WNN_0000000000000380
crossref_primary_10_1016_j_euroneuro_2016_11_002
crossref_primary_10_1016_j_pscychresns_2013_10_002
crossref_primary_10_1111_j_1399_5618_2012_01023_x
crossref_primary_10_1016_j_schres_2014_12_022
crossref_primary_10_1111_j_1528_1167_2012_03504_x
crossref_primary_10_1007_s00429_010_0280_y
crossref_primary_10_1016_j_pscychresns_2012_04_014
crossref_primary_10_1177_20451253231195258
crossref_primary_10_1016_j_biopsych_2010_11_010
crossref_primary_10_1016_j_jad_2015_01_018
crossref_primary_10_1016_j_nicl_2016_06_002
crossref_primary_10_1017_S1092852912000739
crossref_primary_10_1016_j_neubiorev_2013_06_001
crossref_primary_10_1017_S0033291721003809
crossref_primary_10_1038_s41398_020_01049_0
crossref_primary_10_1016_j_biopsych_2011_05_017
crossref_primary_10_1016_j_schres_2020_02_005
crossref_primary_10_3389_fpsyt_2014_00116
crossref_primary_10_1016_j_schres_2009_05_028
crossref_primary_10_1016_j_schres_2013_10_009
crossref_primary_10_1093_schbul_sbs118
crossref_primary_10_1017_S0033291710002163
crossref_primary_10_1016_j_pscychresns_2012_04_002
crossref_primary_10_1002_hup_2574
crossref_primary_10_1093_schbul_sbaf002
crossref_primary_10_1016_j_schres_2012_07_014
crossref_primary_10_1016_j_biopsych_2022_07_017
crossref_primary_10_1017_S1461145711000794
crossref_primary_10_1016_j_biopsych_2010_03_019
crossref_primary_10_1038_s41398_021_01475_8
crossref_primary_10_1186_s40345_018_0124_x
crossref_primary_10_1016_j_ijdevneu_2018_12_004
crossref_primary_10_1016_j_schres_2013_03_002
crossref_primary_10_1155_2014_325052
crossref_primary_10_1016_j_jad_2020_11_064
crossref_primary_10_1016_j_tins_2014_12_005
crossref_primary_10_1016_j_neubiorev_2011_12_015
crossref_primary_10_1017_S1092852920001546
crossref_primary_10_1007_s00234_010_0830_2
crossref_primary_10_1038_s41537_022_00230_2
crossref_primary_10_1007_s11682_020_00284_9
crossref_primary_10_1016_j_pscychresns_2013_09_010
crossref_primary_10_1016_j_neubiorev_2013_10_004
crossref_primary_10_1016_j_schres_2014_11_006
crossref_primary_10_1016_j_neubiorev_2020_10_021
crossref_primary_10_1016_j_neubiorev_2014_12_016
crossref_primary_10_1001_jamapsychiatry_2022_2075
crossref_primary_10_1002_hbm_22075
crossref_primary_10_1016_j_bpsc_2019_01_002
crossref_primary_10_1111_joa_14180
crossref_primary_10_1016_j_nicl_2016_09_006
crossref_primary_10_1093_schbul_sbv173
crossref_primary_10_1016_j_pscychresns_2011_05_005
crossref_primary_10_1016_j_biopsych_2010_12_012
crossref_primary_10_1038_npp_2015_22
crossref_primary_10_1517_13543784_2011_601738
crossref_primary_10_1080_17522430903501999
crossref_primary_10_1017_S0033291711000341
crossref_primary_10_1176_appi_psychotherapy_2016_70_1_5
crossref_primary_10_1177_0004867417699473
crossref_primary_10_1017_S095457941900035X
crossref_primary_10_1093_cercor_bhv255
crossref_primary_10_1007_s12640_010_9178_y
crossref_primary_10_1111_j_1468_1331_2010_03321_x
crossref_primary_10_1016_j_psychres_2023_115345
crossref_primary_10_1016_j_schres_2009_06_022
crossref_primary_10_1186_s12952_015_0030_z
crossref_primary_10_1007_s40263_016_0331_x
crossref_primary_10_1017_S0033291709006060
crossref_primary_10_1016_j_pscychresns_2016_01_010
crossref_primary_10_1016_j_schres_2015_02_023
crossref_primary_10_1089_brain_2017_0519
crossref_primary_10_1017_S1355617711001081
crossref_primary_10_1016_j_pscychresns_2025_111968
crossref_primary_10_1038_s41380_019_0355_y
crossref_primary_10_1038_mp_2015_209
crossref_primary_10_1007_s00429_014_0706_z
crossref_primary_10_1016_j_jad_2020_07_118
crossref_primary_10_1016_j_pscychresns_2018_10_002
crossref_primary_10_1016_j_jpsychires_2012_01_015
crossref_primary_10_1002_hbm_21436
crossref_primary_10_1038_tp_2016_281
Cites_doi 10.1016/S0920-9964(97)00126-6
10.1016/j.biopsych.2005.03.043
10.1523/JNEUROSCI.23-03-00994.2003
10.1001/archpsyc.57.8.761
10.1001/archpsyc.59.11.1002
10.1016/j.pscychresns.2005.06.004
10.1176/ajp.153.4.564
10.1176/ajp.161.10.1829
10.1016/S0006-3223(96)00110-2
10.1176/appi.ajp.162.10.1984-a
10.1016/j.biopsych.2005.02.008
10.1016/S0920-9964(01)00406-6
10.1001/archpsyc.58.2.148
10.1176/ajp.151.10.1430
10.1007/s00213-005-2199-1
10.1038/sj.npp.1300449
10.1176/appi.ajp.158.4.625
10.1001/archpsyc.55.3.235
10.1016/S0140-6736(03)12323-9
10.1016/j.euroneuro.2004.11.005
10.1016/j.pscychresns.2006.04.008
10.1097/01.yco.0000214339.06507.d8
10.1523/JNEUROSCI.18-20-08236.1998
10.1001/archpsyc.62.4.361
10.1001/archpsyc.56.2.133
10.1016/S0920-9964(01)00163-3
10.1001/archpsyc.60.6.585
10.1016/j.schres.2005.10.019
10.1038/sj.npp.1300422
10.1016/S0893-133X(00)00172-X
10.1192/bjp.172.2.110
10.1016/S0893-133X(97)00042-0
10.1176/ajp.156.6.869
10.1017/S1461145704004262
10.1016/j.pscychresns.2003.08.002
10.1073/pnas.201243998
10.1016/S0006-8993(97)01551-5
10.1016/j.schres.2003.08.008
10.1097/01.jcp.0000155818.29091.53
10.1016/S0006-3223(99)00018-9
10.1177/070674370204700106
10.1038/sj.mp.4000581
10.1176/ajp.156.8.1200
10.1001/archpsyc.59.6.553
10.1016/S0006-3223(99)00079-7
10.1176/appi.ajp.158.4.644
10.1016/S0006-3223(00)01001-5
10.1016/S0006-3223(01)01067-8
10.1176/ajp.2006.163.11.2005
10.1097/00001756-200409150-00022
10.1126/science.2867601
10.1016/S0920-9964(01)00330-9
10.1016/S0006-3223(00)01059-3
10.1016/S0140-6736(94)90599-1
10.1093/schbul/sbm168
10.1016/S0140-6736(95)90441-7
10.1038/sj.npp.1300710
10.1016/j.pnpbp.2005.08.019
10.1017/S1121189X00008137
10.1016/S0925-4927(01)00072-5
10.1038/sj.npp.1300603
10.1176/ajp.155.12.1711
10.1001/archpsyc.55.2.145
10.1192/bjp.186.1.26
ContentType Journal Article
Copyright Copyright © Cambridge University Press 2009
2009 INIST-CNRS
Copyright_xml – notice: Copyright © Cambridge University Press 2009
– notice: 2009 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
0-V
3V.
7QJ
7QP
7QR
7RV
7TK
7X7
7XB
88E
88G
8FD
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
ALSLI
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
HEHIP
K9.
KB0
M0S
M1P
M2M
M2O
M2S
MBDVC
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
POGQB
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PRQQA
PSYQQ
Q9U
7X8
DOI 10.1017/S0033291709005315
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Social Sciences Premium Collection【Remote access available】
ProQuest Central (Corporate)
Applied Social Sciences Index & Abstracts (ASSIA)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Technology Research Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Social Science Premium Collection
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection (UHCL Subscription)
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
Sociology Collection (OCUL)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Psychology Database
ProQuest Research Library
Sociology Database (OCUL)
Research Library (Corporate)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest Sociology & Social Sciences Collection
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Social Sciences
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
Sociology & Social Sciences Collection
ProQuest Central China
Health Research Premium Collection
Health & Medical Research Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Sociology
ProQuest Medical Library (Alumni)
Social Science Premium Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Sociology Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Social Sciences Premium Collection
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
Applied Social Sciences Index and Abstracts (ASSIA)
ProQuest Central
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Sociology Collection
ProQuest One Social Sciences
ProQuest Central Basic
ProQuest Nursing & Allied Health Source
ProQuest Psychology Journals (Alumni)
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Neurosciences Abstracts
Applied Social Sciences Index and Abstracts (ASSIA)
ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate S. Navari and P. Dazzan
Systematic review of antipsychotics and brain structure
EISSN 1469-8978
EndPage 1777
ExternalDocumentID 1878121101
19338710
21990770
10_1017_S0033291709005315
ark_67375_6GQ_SZX37K6J_W
Genre Systematic Review
Journal Article
Comparative Study
GroupedDBID ---
-1D
-1F
-2P
-2V
-E.
-~6
-~N
.FH
.GJ
.XZ
0-V
08P
09C
09E
0E1
0R~
123
29P
3V.
4.4
41~
53G
5RE
5VS
6~7
74X
74Y
7RV
7X7
7~V
88E
8FI
8FJ
8G5
8R4
8R5
9M5
AAAZR
AABES
AABWE
AACJH
AAGFV
AAKTX
AAMNQ
AARAB
AASVR
AATMM
AAUIS
AAUKB
AAWTL
AAYEP
ABBXD
ABBZL
ABGDZ
ABITZ
ABIVO
ABJNI
ABKKG
ABLJU
ABQTM
ABQWD
ABROB
ABTCQ
ABUWG
ABVFV
ABVKB
ABVZP
ABWCF
ABXAU
ABZCX
ABZUI
ACBMC
ACDLN
ACETC
ACGFO
ACGFS
ACHQT
ACIMK
ACIWK
ACPRK
ACRPL
ACUIJ
ACYZP
ACZBM
ACZUX
ADAZD
ADBBV
ADDNB
ADFEC
ADFRT
ADKIL
ADNMO
ADOVH
ADOVT
ADVJH
AEBAK
AEBPU
AEHGV
AEMFK
AEMTW
AENCP
AENEX
AENGE
AEPLO
AEYHU
AEYYC
AFFNX
AFFUJ
AFKQG
AFKRA
AFLOS
AFLVW
AFUTZ
AFZFC
AGABE
AGJUD
AGLWM
AHIPN
AHLTW
AHMBA
AHQXX
AHRGI
AIGNW
AIHIV
AIOIP
AISIE
AJ7
AJCYY
AJPFC
AJQAS
AKZCZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
ALVPG
ANPSP
AQJOH
ARABE
ARALO
ARZZG
ASOEW
ATUCA
AUXHV
AYIQA
AZGZS
AZQEC
BBLKV
BCGOX
BENPR
BESQT
BGHMG
BJBOZ
BKEYQ
BLZWO
BMAJL
BPHCQ
BQFHP
BRIRG
BVXVI
C0O
C45
CAG
CBIIA
CCPQU
CCQAD
CCUQV
CDIZJ
CFAFE
CFBFF
CGQII
CHEAL
CJCSC
COF
CS3
DC4
DOHLZ
DU5
DWQXO
EBS
EGQIC
EJD
EX3
F5P
FA8
FYUFA
GNUQQ
GUQSH
HEHIP
HG-
HMCUK
HST
HZ~
H~9
I.6
I.7
I.9
IH6
IOEEP
IOO
IS6
I~P
J36
J38
J3A
J5H
JHPGK
JQKCU
JVRFK
KAFGG
KCGVB
KFECR
L7B
L98
LHUNA
LW7
M-V
M1P
M2M
M2O
M2S
M7~
M8.
N4W
NAPCQ
NEJ
NIKVX
NMFBF
NZEOI
O9-
OMB
OMC
OMH
OVD
OYBOY
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RCA
RIG
ROL
RR0
S6-
S6U
SAAAG
SY4
T9M
TEORI
UAP
UCJ
UKHRP
UT1
UU6
VVN
WFFJZ
WH7
WOW
WQ3
WXU
WYP
YOC
YZZ
ZCA
ZDLDU
ZGI
ZJOSE
ZMEZD
ZXP
ZYDXJ
~V1
AAFWJ
AAKNA
ABXHF
ACEJA
ADPDF
AGQPQ
AKMAY
ANOYL
BSCLL
IPYYG
PHGZM
PHGZT
PJZUB
POGQB
PPXIY
PRQQA
PUEGO
AAYXX
ABHFL
ACOZI
CITATION
AGKLZ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7QP
7QR
7TK
7XB
8FD
8FK
FR3
K9.
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c567t-815a3780221e123de2703f19833fdcb8c2e56d2c549d56e782b14adbc87ddcad3
IEDL.DBID 7X7
ISSN 0033-2917
1469-8978
IngestDate Fri Jul 11 09:00:36 EDT 2025
Fri Jul 11 12:02:37 EDT 2025
Fri Jul 11 15:37:52 EDT 2025
Fri Jul 25 04:14:45 EDT 2025
Mon Jul 21 05:55:08 EDT 2025
Mon Mar 31 10:56:58 EDT 2025
Tue Jul 01 02:14:21 EDT 2025
Thu Apr 24 23:01:48 EDT 2025
Sun Aug 31 06:48:18 EDT 2025
Tue Jan 21 06:23:42 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Antipsychotic drugs
brain
MRI
psychosis
Human
Volumetric analysis
Cerebral cortex
Neuroleptic
Psychotropic
Central nervous system
Pharmacotherapy
Basal ganglion
Review
Nuclear magnetic resonance imaging
Encephalon
Psychosis
Treatment
Medical imagery
Critical study
Thalamus
Biological effect
Language English
License https://www.cambridge.org/core/terms
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-815a3780221e123de2703f19833fdcb8c2e56d2c549d56e782b14adbc87ddcad3
Notes ArticleID:00531
PII:S0033291709005315
ark:/67375/6GQ-SZX37K6J-W
istex:541847A7BEBAD118197E5D34413B3E2E98713905
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
ObjectType-Undefined-4
PMID 19338710
PQID 204495127
PQPubID 35753
PageCount 15
ParticipantIDs proquest_miscellaneous_734072869
proquest_miscellaneous_57311673
proquest_miscellaneous_21330453
proquest_journals_204495127
pubmed_primary_19338710
pascalfrancis_primary_21990770
crossref_primary_10_1017_S0033291709005315
crossref_citationtrail_10_1017_S0033291709005315
istex_primary_ark_67375_6GQ_SZX37K6J_W
cambridge_journals_10_1017_S0033291709005315
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-11-01
PublicationDateYYYYMMDD 2009-11-01
PublicationDate_xml – month: 11
  year: 2009
  text: 2009-11-01
  day: 01
PublicationDecade 2000
PublicationPlace Cambridge, UK
PublicationPlace_xml – name: Cambridge, UK
– name: Cambridge
– name: England
PublicationTitle Psychological medicine
PublicationTitleAlternate Psychol. Med
PublicationYear 2009
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
References S0033291709005315_ref02a
Frazier (S0033291709005315_ref017) 1996; 153
S0033291709005315_ref042
S0033291709005315_ref041
S0033291709005315_ref002
S0033291709005315_ref046
S0033291709005315_ref001
S0033291709005315_ref045
S0033291709005315_ref044
S0033291709005315_ref043
S0033291709005315_ref006
S0033291709005315_ref049
S0033291709005315_ref005
S0033291709005315_ref048
S0033291709005315_ref003
S0033291709005315_ref047
S0033291709005315_ref008
S0033291709005315_ref03a
Cohen (S0033291709005315_ref007) 1992; 112
S0033291709005315_ref053
S0033291709005315_ref052
S0033291709005315_ref051
S0033291709005315_ref050
S0033291709005315_ref013
S0033291709005315_ref057
S0033291709005315_ref012
S0033291709005315_ref011
S0033291709005315_ref055
S0033291709005315_ref054
S0033291709005315_ref016
S0033291709005315_ref015
S0033291709005315_ref059
S0033291709005315_ref058
S0033291709005315_ref014
S0033291709005315_ref019
S0033291709005315_ref018
S0033291709005315_ref060
S0033291709005315_ref064
S0033291709005315_ref020
S0033291709005315_ref063
S0033291709005315_ref062
S0033291709005315_ref061
S0033291709005315_ref024
Dazzan (S0033291709005315_ref010) 2005; 30
S0033291709005315_ref023
S0033291709005315_ref022
S0033291709005315_ref065
S0033291709005315_ref021
S0033291709005315_ref028
S0033291709005315_ref027
S0033291709005315_ref026
S0033291709005315_ref025
Chakos (S0033291709005315_ref004) 1994; 151
S0033291709005315_ref029
Corson (S0033291709005315_ref009) 1999; 156
S0033291709005315_ref01a
S0033291709005315_ref031
S0033291709005315_ref030
S0033291709005315_ref035
S0033291709005315_ref034
S0033291709005315_ref033
S0033291709005315_ref032
S0033291709005315_ref038
S0033291709005315_ref037
S0033291709005315_ref036
23651623 - Psychol Med. 2013 Jul;43(7):1568. doi: 10.1017/S0033291713001001.
19379533 - Psychol Med. 2009 Nov;39(11):1779-80. doi: 10.1017/S003329170900573X.
19476691 - Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060.
References_xml – ident: S0033291709005315_ref065
  doi: 10.1016/S0920-9964(97)00126-6
– ident: S0033291709005315_ref01a
  doi: 10.1016/j.biopsych.2005.03.043
– ident: S0033291709005315_ref059
  doi: 10.1523/JNEUROSCI.23-03-00994.2003
– ident: S0033291709005315_ref022
  doi: 10.1001/archpsyc.57.8.761
– ident: S0033291709005315_ref002
  doi: 10.1001/archpsyc.59.11.1002
– ident: S0033291709005315_ref058
  doi: 10.1016/j.pscychresns.2005.06.004
– volume: 153
  start-page: 564
  year: 1996
  ident: S0033291709005315_ref017
  article-title: Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment
  publication-title: American Journal of Psychiatry
  doi: 10.1176/ajp.153.4.564
– ident: S0033291709005315_ref031
  doi: 10.1176/ajp.161.10.1829
– ident: S0033291709005315_ref044
  doi: 10.1016/S0006-3223(96)00110-2
– ident: S0033291709005315_ref054
  doi: 10.1176/appi.ajp.162.10.1984-a
– ident: S0033291709005315_ref019
  doi: 10.1016/j.biopsych.2005.02.008
– ident: S0033291709005315_ref057
  doi: 10.1016/S0920-9964(01)00406-6
– ident: S0033291709005315_ref036
  doi: 10.1001/archpsyc.58.2.148
– volume: 151
  start-page: 1430
  year: 1994
  ident: S0033291709005315_ref004
  article-title: Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
  publication-title: American Journal of Psychiatry
  doi: 10.1176/ajp.151.10.1430
– ident: S0033291709005315_ref041
  doi: 10.1007/s00213-005-2199-1
– ident: S0033291709005315_ref062
  doi: 10.1038/sj.npp.1300449
– ident: S0033291709005315_ref030
  doi: 10.1176/appi.ajp.158.4.625
– ident: S0033291709005315_ref03a
  doi: 10.1001/archpsyc.55.3.235
– ident: S0033291709005315_ref047
  doi: 10.1016/S0140-6736(03)12323-9
– ident: S0033291709005315_ref001
  doi: 10.1016/j.euroneuro.2004.11.005
– ident: S0033291709005315_ref038
  doi: 10.1016/j.pscychresns.2006.04.008
– ident: S0033291709005315_ref052
  doi: 10.1097/01.yco.0000214339.06507.d8
– ident: S0033291709005315_ref048
  doi: 10.1523/JNEUROSCI.18-20-08236.1998
– ident: S0033291709005315_ref034
  doi: 10.1001/archpsyc.62.4.361
– ident: S0033291709005315_ref061
  doi: 10.1001/archpsyc.56.2.133
– ident: S0033291709005315_ref055
  doi: 10.1016/S0920-9964(01)00163-3
– ident: S0033291709005315_ref026
  doi: 10.1001/archpsyc.60.6.585
– ident: S0033291709005315_ref020
  doi: 10.1016/j.schres.2005.10.019
– volume: 112
  start-page: 115
  year: 1992
  ident: S0033291709005315_ref007
  article-title: A power primer
  publication-title: Psychiatric Bulletin
– ident: S0033291709005315_ref024
  doi: 10.1038/sj.npp.1300422
– ident: S0033291709005315_ref050
  doi: 10.1016/S0893-133X(00)00172-X
– ident: S0033291709005315_ref032
  doi: 10.1192/bjp.172.2.110
– ident: S0033291709005315_ref042
  doi: 10.1016/S0893-133X(97)00042-0
– ident: S0033291709005315_ref045
  doi: 10.1176/ajp.156.6.869
– ident: S0033291709005315_ref046
  doi: 10.1017/S1461145704004262
– ident: S0033291709005315_ref006
  doi: 10.1016/j.pscychresns.2003.08.002
– ident: S0033291709005315_ref060
  doi: 10.1073/pnas.201243998
– ident: S0033291709005315_ref064
  doi: 10.1016/S0006-8993(97)01551-5
– ident: S0033291709005315_ref025
  doi: 10.1016/j.schres.2003.08.008
– ident: S0033291709005315_ref035
  doi: 10.1097/01.jcp.0000155818.29091.53
– ident: S0033291709005315_ref037
  doi: 10.1016/S0006-3223(99)00018-9
– ident: S0033291709005315_ref053
  doi: 10.1177/070674370204700106
– ident: S0033291709005315_ref015
  doi: 10.1038/sj.mp.4000581
– volume: 156
  start-page: 1200
  year: 1999
  ident: S0033291709005315_ref009
  article-title: Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics
  publication-title: American Journal of Psychiatry
  doi: 10.1176/ajp.156.8.1200
– ident: S0033291709005315_ref063
  doi: 10.1001/archpsyc.59.6.553
– ident: S0033291709005315_ref008
  doi: 10.1016/S0006-3223(99)00079-7
– ident: S0033291709005315_ref051
  doi: 10.1176/appi.ajp.158.4.644
– ident: S0033291709005315_ref043
  doi: 10.1016/S0006-3223(00)01001-5
– ident: S0033291709005315_ref033
  doi: 10.1016/S0006-3223(01)01067-8
– ident: S0033291709005315_ref029
  doi: 10.1176/ajp.2006.163.11.2005
– ident: S0033291709005315_ref018
  doi: 10.1097/00001756-200409150-00022
– ident: S0033291709005315_ref016
  doi: 10.1126/science.2867601
– ident: S0033291709005315_ref013
  doi: 10.1016/S0920-9964(01)00330-9
– ident: S0033291709005315_ref02a
  doi: 10.1016/S0006-3223(00)01059-3
– ident: S0033291709005315_ref028
  doi: 10.1016/S0140-6736(94)90599-1
– ident: S0033291709005315_ref027
  doi: 10.1093/schbul/sbm168
– ident: S0033291709005315_ref003
  doi: 10.1016/S0140-6736(95)90441-7
– ident: S0033291709005315_ref014
  doi: 10.1038/sj.npp.1300710
– ident: S0033291709005315_ref012
  doi: 10.1016/j.pnpbp.2005.08.019
– ident: S0033291709005315_ref011
  doi: 10.1017/S1121189X00008137
– ident: S0033291709005315_ref049
  doi: 10.1016/S0925-4927(01)00072-5
– volume: 30
  start-page: 765
  year: 2005
  ident: S0033291709005315_ref010
  article-title: Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the ÆSOP study
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300603
– ident: S0033291709005315_ref023
  doi: 10.1176/ajp.155.12.1711
– ident: S0033291709005315_ref021
  doi: 10.1001/archpsyc.55.2.145
– ident: S0033291709005315_ref005
  doi: 10.1192/bjp.186.1.26
– reference: 23651623 - Psychol Med. 2013 Jul;43(7):1568. doi: 10.1017/S0033291713001001.
– reference: 19379533 - Psychol Med. 2009 Nov;39(11):1779-80. doi: 10.1017/S003329170900573X.
– reference: 19476691 - Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060.
SSID ssj0013142
Score 2.449611
SecondaryResourceType review_article
Snippet The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review...
Background: The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This...
Background. The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
cambridge
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1763
SubjectTerms Anatomy & physiology
Antipsychotic Agents - adverse effects
Antipsychotic Agents - therapeutic use
Antipsychotic drugs
Basal Ganglia - drug effects
Basal Ganglia - pathology
Biological and medical sciences
Brain
Brain - drug effects
Brain - pathology
Brain structure
Cerebral Cortex - drug effects
Cerebral Cortex - pathology
Cortex
Cross-Sectional Studies
Dominance, Cerebral - drug effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug therapy
Gyrus Cinguli - drug effects
Gyrus Cinguli - pathology
Humans
Longitudinal Studies
Magnetic Resonance Imaging
Medical imaging
Medical sciences
Mesencephalon - drug effects
MRI
Neuropharmacology
Neuropsychology
Organ Size - drug effects
Pharmacology. Drug treatments
Psycholeptics: tranquillizer, neuroleptic
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Psychoses
psychosis
Psychotic Disorders - diagnosis
Psychotic Disorders - drug therapy
Psychotic Disorders - pathology
Psychotropic drugs
Reference Values
Schizophrenia
Schizophrenia - diagnosis
Schizophrenia - drug therapy
Schizophrenia - pathology
Subject headings
Systematic review
Thalamus - drug effects
Thalamus - pathology
Title Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings
URI https://www.cambridge.org/core/product/identifier/S0033291709005315/type/journal_article
https://api.istex.fr/ark:/67375/6GQ-SZX37K6J-W/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/19338710
https://www.proquest.com/docview/204495127
https://www.proquest.com/docview/21330453
https://www.proquest.com/docview/57311673
https://www.proquest.com/docview/734072869
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdglRAvCDZgYVD8gPaAiBTH8UeepgIbY6gTDCYqXiJ_ZZqAZDSrBP89Z8dNmVD76txJ8fls3_nufofQC5MzCreISmstwUExuUlLpcs0rwm3UvFaC187PD3lx-fFyYzNYm5OF9Mql2diOKhta_wbOTjpBdjyJBcHV79S3zTKB1djB43baOSRy7zvJWZiFUQgRQ8WHtqVEbEMagbEaBj0Y1kZ1JD9C61w44oaeWn_9imTqgOp1X27i_X2aLiXju6je9GgxJNeAx6gW67ZRjuTBpzpn3_wPg4pnuHtfBvdmcZI-g6q3rYYhHoZq7AuDbbzxUWHVcjvwNp3jsA9uOxi7g7wBK8wn4HRYhN7JOC--AW3NZ6evcchBt5cdA_R-dHhlzfHaWy2kBrGxXUqCVNU-MJb4uA2sy6Hs6AmpaS0tkZLkzvGbW7An7SMOzAsNCmU1UYKa42y9BHaatrG7SJsLZFgWRSSGgUkRtuMaZG7mpeFKWWZoFeDrKu4ZbqqTzcT1X9Lk6BsuRyVicDlvn_Gj00sLweWqx61YxPxfljjgVLNv_t0N8Eq_u5T9fnbjIoP_KT6mqDxDSUYGODULzMhsgTtLbViNa9BcRP0fPgKe9gHZlTj2gWQEP-qxOh6CiaoD5gBBV5DIaiHupMcpPu418fVzEtKwS_Onmz8vT10N0TKQp3lU7QFGuaegcF1rcdhW43R6PXh6cezv6TOJKU
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFRaCbggaHmEQusD9ICIlNhxnBxQtaKU3W63EtCKFZfg2E5V0SZltyvoR_GPjJ3HUqHdW6_JTBR7ZjwznhfAK0U5Qy0i_SJP0EFRVPmpzFOfFmGsExkXubC1w6OjuH8SHYz5eAX-tLUwNq2yPRPdQa0rZe_I0UmP0JYPqdi9_OnboVE2uNpO0Ki5Ymiuf6HHNn032EPyvqZ0_8Px-77fDBXwFY_FlZ-EXDJhC0xDg6e2NhR5vkDXm7FCqzxR1PBYU4V-k-axQQWah5HUuUqE1kpqht-9A2uodwObQSjGYh60CKO6ObkbjxaKNojqOlTjQ_ssSB3b839bOdxQiWuWur9tiqacIpWKerzGYvvX6cH9h_CgMWBJr-a4R7BiynXY6JXovF9ckx3iUkrdXf063B01kfsNyPYqgkQ8a6q-zhTRk9nplEiXT0JyO6mC1M1sZxOzS3pk3mMaETVRzUwGUhfbkKogo88D4mLu5en0MZzcCh2ewGpZleYZEK3DBC2ZKGFKIojKdcBzQU0Rp5FKk9SDt91eZ42ITrM6vU1k_5HGg6AlR6aaRul2Xsf5MpQ3Hcpl3SVkGfCOo3EHKSc_bHqd4Fn88VP25duYiWF8kH31YOsGE3QIqGXSQIjAg82WK-br6gTFg-3uLZ4ZNhAkS1PNECS0t1icLYbggtkAHUKQBRCC2dZ6SYy7-7Tmx_nKU8bQDw-eL_29bbjXPx4dZoeDo-Em3HdROlfj-QJWkdvMSzT2rvItJ2IEvt-2TP8Fg89gDA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFRaqeKCoOURCq0P0AMiUhLHcXJA1Ypl6XbZilfFqpfgV6oKSMpuV9BP4-8YO4-lQru3Xp1xZHtmPDOeF8AzFTGKUkT4hUzRQFGR8jMhMz8qwkSnIikkt7nD4-Pk8CQ-mrDJGvxpc2FsWGV7J7qLWlfKvpGjkR6jLh-ipV40URHv-4ODi5--bSBlHa1tN42aQkbm6hdab7NXwz6i-nkUDd58fn3oNw0GfMUSfumnIROU22TT0OANrk2E9F-gGU5poZVMVWRYoiOFNpRmiUFhKsNYaKlSrrUSmuJ_b8EGp7guZCU-4QsHRhjXhcpdq7SQtw5VV60aB-1YkDkWYP-WdbgmHjcspn_bcE0xQ4wVdauN5bqwk4mDu3CnUWZJr6a-e7Bmyi3Y7pVoyP-4IvvEhZe6d_st2Bw3XvxtyPsVQYSeNxlg54ro6fxsRoSLLSHSdq0gdWHb-dQckB5Z1JvGiZqopj8DqRNvSFWQ8cchcf738mx2H05uBA8PYL2sSvMIiNZhilpNnFIlEERJHTDJI1MkWayyNPPgZXfWecOus7wOdeP5f6jxIGjRkaumaLrt3fF91ZQX3ZSLumLIKuB9h-MOUky_2VA7zvLk7Yf80-mE8lFylH_xYPcaEXQTUOJkAeeBBzstVSz21TGNB3vdV7w_rFNIlKaaI0hoX7QYXQ7BOLXOOoQgSyA4tWX20gRP92FNj4udZ5SiTR48Xrm8PdhEbs7fDY9HO3DbOexcuucTWEdiM09R77uUu47DCHy9aZb-C1QCZEI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Do+antipsychotic+drugs+affect+brain+structure%3F+A+systematic+and+critical+review+of+MRI+findings&rft.jtitle=Psychological+medicine&rft.au=Navari%2C+S&rft.au=Dazzan%2C+P&rft.date=2009-11-01&rft.eissn=1469-8978&rft.volume=39&rft.issue=11&rft.spage=1763&rft_id=info:doi/10.1017%2FS0033291709005315&rft_id=info%3Apmid%2F19338710&rft.externalDocID=19338710
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-2917&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-2917&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-2917&client=summon